Licensing

TrichoScience anticipates marketing and distributing its procedure through a licensing model. Upon successful completion of human clinical trials, the TrichoScience procedure would be offered to hair loss/dermatology clinics and those medical professionals currently engaged in hair transplant and similar hair restorative programs. Access to, and application of, the company's procedure would be offered under terms and conditions of a detailed, all-encompassing licensing agreement. The agreement would cover two specific areas:

1) Procedure Access & Training (PAT) rights covering doctor/clinic access to the TrichoScience procedure and training; and

2) Biopsy & Cell Replication (BCR) rights covering doctor/clinic access to TrichoScience-approved laboratories for the cell replication process.

Under terms of the anticipated licensing agreement, TrichoScience would control all aspects of how the procedure is marketed, positioned, promoted and priced by the licensees. TrichoScience would also control the training of the technicians/clinicians "registered" or "authorized" to administer the company's procedure.